• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量分析复制缺陷型腺病毒载体转导细胞中腺病毒基因的渗漏表达。

Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector.

机构信息

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.

出版信息

Mol Pharm. 2011 Aug 1;8(4):1430-5. doi: 10.1021/mp200121z. Epub 2011 Jun 17.

DOI:10.1021/mp200121z
PMID:21682288
Abstract

Theoretically, adenovirus (Ad) genes should not be expressed following transduction with a replication-incompetent Ad vector because the E1A gene, which is essential for the expression of other viral gene, is deleted in a replication-incompetent Ad vector. However, leaky expression of viral genes is known to occur following transduction with an E1-deleted Ad vector, leading to an induction of cellular immunity against Ad proteins. To date, no detailed analysis of the leaky expression profiles of Ad genes has been performed. In this study, we systematically examined the expression profiles of Ad genes in cells following transduction with a replication-incompetent Ad vector (Ad-L2) at multiplicities of infection (MOIs) of 10 and 100 using real-time RT-PCR. Significant expression was found for the E4 and pIX genes following transduction with Ad-L2 in cultured cells. The expression levels of the E4 and pIX genes were approximately 30- to 600-fold lower than those of the transgene (firefly luciferase), and 50- to 5000-fold lower than those of the E4 and pIX genes following transduction at the same MOI with the wild-type Ad. Unexpectedly, expression levels of the major capsid proteins were approximately the same as, or even slightly above, the background levels (Ad gene expression levels in mock-transduced cells). This study provides valuable information for the design of a safe and efficient replication-incompetent Ad vector.

摘要

从理论上讲,腺病毒(Ad)基因在转导无复制能力的腺病毒载体后不应表达,因为 E1A 基因对于其他病毒基因的表达是必不可少的,而在无复制能力的腺病毒载体中已被删除。然而,已知在转导 E1 缺失的腺病毒载体后会发生病毒基因的渗漏表达,导致针对腺病毒蛋白的细胞免疫诱导。迄今为止,尚未对腺病毒基因的渗漏表达谱进行详细分析。在这项研究中,我们使用实时 RT-PCR 系统地检查了在感染复数(MOI)为 10 和 100 时,无复制能力的腺病毒载体(Ad-L2)转导后细胞中腺病毒基因的表达谱。在培养的细胞中转导 Ad-L2 后,发现 E4 和 pIX 基因的表达显著。E4 和 pIX 基因的表达水平比转导时的转基因(萤火虫荧光素酶)低约 30-600 倍,比相同 MOI 下野生型 Ad 转导时的 E4 和 pIX 基因低 50-5000 倍。出乎意料的是,主要衣壳蛋白的表达水平与背景水平(未经转导的细胞中的腺病毒基因表达水平)大致相同,甚至略高。这项研究为设计安全有效的无复制能力的腺病毒载体提供了有价值的信息。

相似文献

1
Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector.定量分析复制缺陷型腺病毒载体转导细胞中腺病毒基因的渗漏表达。
Mol Pharm. 2011 Aug 1;8(4):1430-5. doi: 10.1021/mp200121z. Epub 2011 Jun 17.
2
[Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].[一种新型腺病毒载体的开发,该载体表现出微小RNA介导的对腺病毒基因渗漏表达的抑制作用]
Yakugaku Zasshi. 2012;132(12):1407-12. doi: 10.1248/yakushi.12-00235-5.
3
Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells.几种纤维修饰腺病毒载体介导的转基因在滋养层细胞中的表达比较。
Placenta. 2005 Nov;26(10):729-34. doi: 10.1016/j.placenta.2004.10.010. Epub 2004 Dec 16.
4
[Development and Characterization of a Novel Adenovirus Vector Exhibiting MicroRNA-mediated Suppression of the Leaky Expression of Adenovirus Genes].[一种新型腺病毒载体的开发与特性研究,该载体表现出微小RNA介导的对腺病毒基因渗漏表达的抑制作用]
Yakugaku Zasshi. 2015;135(12):1349-56. doi: 10.1248/yakushi.15-00190.
5
Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.利用病毒基因组的包装大小限制,开发一种无复制能力的重组腺病毒载体生产系统。
Virus Res. 2011 Jun;158(1-2):154-60. doi: 10.1016/j.virusres.2011.03.026. Epub 2011 Apr 4.
6
Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.共表达腺病毒E1、DNA聚合酶和前末端蛋白的包装细胞系的分离与鉴定:对基因治疗的意义
Gene Ther. 1997 Mar;4(3):258-63. doi: 10.1038/sj.gt.3300378.
7
Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.通过GAL4-TATA启动子替换缺失E1-E3并使E4失活的腺病毒载体,降低体内毒性、减弱免疫原性并有效介导人p53基因表达。
Gene Ther. 1999 Mar;6(3):393-402. doi: 10.1038/sj.gt.3300825.
8
Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.多重缺失的[E1、聚合酶和前末端蛋白缺失]腺病毒载体尽管前末端蛋白缺失仍能持续存在。
J Gene Med. 2000 Jul-Aug;2(4):250-9. doi: 10.1002/1521-2254(200007/08)2:4<250::AID-JGM113>3.0.CO;2-3.
9
Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.腺病毒血清型 35 载体诱导源自野生型和人 CD46 转基因小鼠的树突状细胞的固有免疫反应:与含有腺病毒血清型 35 纤维蛋白的纤维替代型 Ad 载体的比较。
J Control Release. 2010 Dec 1;148(2):212-8. doi: 10.1016/j.jconrel.2010.08.025. Epub 2010 Aug 26.
10
Development of an adenovirus vector lacking the expression of virus-associated RNAs.开发一种缺乏病毒相关 RNA 表达的腺病毒载体。
J Control Release. 2011 Sep 25;154(3):285-9. doi: 10.1016/j.jconrel.2011.06.020. Epub 2011 Jun 16.

引用本文的文献

1
Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.新型条件复制型腺病毒介导的肺癌患者循环肿瘤细胞的高效检测。
PLoS One. 2023 Oct 19;18(10):e0286323. doi: 10.1371/journal.pone.0286323. eCollection 2023.
2
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.靶向细胞周期促进 E1A 非依赖性腺病毒复制。
J Virol. 2023 Jun 29;97(6):e0037023. doi: 10.1128/jvi.00370-23. Epub 2023 May 23.
3
Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination.
接种ChAdOx1 nCoV-19、BNT162b2与科兴新冠疫苗后对SARS-CoV-2奥密克戎毒株的易感性
iScience. 2022 Nov 18;25(11):105379. doi: 10.1016/j.isci.2022.105379. Epub 2022 Oct 17.
4
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action.当前新冠疫苗的显著特征:抗原呈递和作用方式的已知与未知
NPJ Vaccines. 2021 Aug 16;6(1):104. doi: 10.1038/s41541-021-00369-6.
5
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription.SARS-CoV-2 疫苗 ChAdOx1 nCoV-19 感染人细胞系时,病毒骨架基因转录水平较低,而 SARS-CoV-2 S 糖蛋白基因转录水平非常高。
Genome Med. 2021 Mar 15;13(1):43. doi: 10.1186/s13073-021-00859-1.
6
Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes.新型腺病毒载体用于B型血友病的新生儿基因治疗,该载体显示病毒基因的渗漏表达减少。
Mol Ther Methods Clin Dev. 2017 Jul 8;6:183-193. doi: 10.1016/j.omtm.2017.07.001. eCollection 2017 Sep 15.
7
The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Can Mimic E1A Effects on E2F.人5型腺病毒E4orf6/E1B55K E3泛素连接酶复合物可模拟E1A对E2F的作用。
mSphere. 2015 Nov 11;1(1). doi: 10.1128/mSphere.00014-15. eCollection 2016 Jan-Feb.
8
NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.核因子κB促进无复制能力的腺病毒载体中腺病毒基因的渗漏表达。
Sci Rep. 2016 Jan 27;6:19922. doi: 10.1038/srep19922.
9
Lung gene therapy-How to capture illumination from the light already present in the tunnel.肺部基因治疗——如何从隧道中已有的光线中捕捉光亮。
Genes Dis. 2014 Sep;1(1):40-52. doi: 10.1016/j.gendis.2014.06.001.
10
Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.利用微 RNA 调控的辅助依赖性 Ad5/35 载体表达靶向内切酶对造血干细胞进行高效基因组编辑。
Mol Ther Methods Clin Dev. 2015 Jan 14;1:14057. doi: 10.1038/mtm.2014.57. eCollection 2015.